View Older Stories View More Recent Stories

Nov 16, 2023 04:05PM Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
Sep 6, 2023 04:05PM Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work
Mar 2, 2023 09:16AM Myriad Genetics (MYGN) and Illumina (ILMN) Expand Partnership for HRD Testing in the US
Mar 2, 2023 09:15AM Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Mar 2, 2023 09:15AM Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Mar 2, 2023 09:15AM Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Nov 29, 2022 04:05PM Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Showcasing Advancements in Breast Cancer Risk Assessment and Treatment
Nov 29, 2022 04:05PM Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Showcasing Advancements in Breast Cancer Risk Assessment and Treatment
Nov 14, 2022 08:00AM Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting
Nov 14, 2022 08:00AM Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting
Jun 22, 2022 06:02AM Illumina (ILMN) Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
Jun 22, 2022 06:00AM Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
Nov 22, 2021 07:05AM Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment
Nov 22, 2021 07:05AM Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment
Sep 7, 2021 09:15AM Illumina (ILMN) Partners with Merck (MRK) to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations
Sep 7, 2021 09:15AM Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations
May 19, 2021 05:55PM Myriad Genetics to Share New Data at 2021 ASCO Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries
May 19, 2021 05:55PM Myriad Genetics to Share New Data at 2021 ASCO Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries
Dec 11, 2020 07:05AM New Study Provides Personalized Breast Cancer Risk Information for Women with ATM Gene Mutations
Dec 11, 2020 07:05AM New Study Provides Personalized Breast Cancer Risk Information for Women with ATM Gene Mutations
May 29, 2020 07:07AM Myriad Genetics (MYGN) Highlights New Data Validating Ability of riskScore to Provide Personalized Breast Cancer Risk Information to Patients
May 29, 2020 07:05AM Myriad Presents New Data at ASCO Validating the Ability of riskScore® to Provide Personalized Breast Cancer Risk Information to Patients
May 29, 2020 07:05AM Myriad Presents New Data at ASCO Validating the Ability of riskScore® to Provide Personalized Breast Cancer Risk Information to Patients
Dec 14, 2019 07:05AM Myriad’s Polygenic Risk Score Personalizes Risk of Breast Cancer for Woman with a Genetic Mutation in Important Breast Cancer Genes
Dec 14, 2019 07:05AM Myriad’s Polygenic Risk Score Personalizes Risk of Breast Cancer for Woman with a Genetic Mutation in Important Breast Cancer Genes
Dec 3, 2019 07:05AM Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium
Dec 3, 2019 07:05AM Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium
Nov 9, 2019 04:30PM New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis
Nov 9, 2019 04:30PM New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis
Nov 1, 2019 07:05AM Myriad Genetics Announces Multiple Presentations at the 2019 American College of Rheumatology Annual Meeting
Nov 1, 2019 07:05AM Myriad Genetics Announces Multiple Presentations at the 2019 American College of Rheumatology Annual Meeting
Oct 28, 2019 07:05AM Myriad Genetics to Present Seven Studies at the 2019 National Society of Genetic Counselors Annual Meeting
Oct 28, 2019 07:05AM Myriad Genetics to Present Seven Studies at the 2019 National Society of Genetic Counselors Annual Meeting
Oct 8, 2019 07:05AM Myriad Genetics to Present Five Studies at the 2019 American Society of Human Genetics Annual Meeting
Oct 8, 2019 07:05AM Myriad Genetics to Present Five Studies at the 2019 American Society of Human Genetics Annual Meeting
Aug 22, 2019 07:05AM Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention
Aug 22, 2019 07:05AM Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention
Jun 3, 2019 07:13AM Myriad Genetics (MYGN) Announces New Results from Two Large Studies of Its myRisk Hereditary Cancer Test at ASCO
Jun 3, 2019 07:05AM Myriad Genetics Announces New Results from Two Large Studies of Its myRisk® Hereditary Cancer Test at American Society of Clinical Oncology
Jun 3, 2019 07:05AM Myriad Genetics Announces New Results from Two Large Studies of Its myRisk® Hereditary Cancer Test at American Society of Clinical Oncology
May 14, 2019 07:05AM Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
May 14, 2019 07:05AM Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
Apr 30, 2019 11:19AM Myriad Genetics (MYGN) Says EndoPredict Predicts Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast Cancer
Apr 30, 2019 11:17AM EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast Cancer
Apr 30, 2019 11:17AM EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast Cancer
Apr 23, 2019 07:05AM Myriad to Present Multiple Women’s Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual Meeting
Apr 23, 2019 07:05AM Myriad to Present Multiple Women’s Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual Meeting
Apr 17, 2019 07:05AM Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List
Apr 17, 2019 07:05AM Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List
Apr 4, 2019 07:08AM Myriad Genetics (MYGN), AstraZeneca (AZN) and Merck (MRK) Expand Companion Diagnostic Partnership
View More Recent Stories View Older Stories